Saturday, August 9, 2025

CloudMD Telehealth Platform Increases Onboarding

CloudMD Software & Services (CSE: DOC) announced this morning that they are currently in the process of increasing doctor onboarding for their flagship telemedicine platform. The increase in onboarding comes as the coronavirus outbreak continues to develop across North America.

Increased onboarding is being conducted as officials from major health organizations, such as the CDC and the World Health Organization push the use of telemedicine services to assist in reducing the spread of the novel coronavirus. Telemedicine visits reduce the transmission of the viral disease due to reduced exposure to medical offices and public settings.

As demand for our services is expected to rise amidst the current Coronavirus outbreak, we are increasing our physician recruitment to manage the increased demand. It’s better to triage patients remotely, sending only complex cases to over-stretched hospitals, allowing for a more efficient use of healthcare resources and ultimately higher quality of care for the patient population.

Dr. Essam Hamza, CEO of CloudMD

Additionally, CloudMD has also announced that its previously announced private placement for $3.0 million has seen the base offering fully subscribed to. The financing was lead by Gravitas Securities, and is expected to close March 11.

CloudMD Software & Services last traded at $0.52 on the CSE.


FULL DISCLOSURE: CloudMD Software & Services is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover CloudMD Software & Services on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

New Found Gold: The Queensway PEA

Newmont Q2 Earnings: Setting The Tone For This Earnings Cycle

Highest Grade Antimony Mine in the World!? | James Atkinson – Antimony Resources

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

CloudMD: Canaccord Reiterates $3.00 Price Target After Q3 Results

On November 29th, CloudMD Software & Services Inc. (TSXV: DOC) announced its third quarter financial...

Wednesday, December 1, 2021, 03:36:00 PM

Canaccord Raises CloudMD Price Target To $1.75 Following Financial Results

On Monday, CloudMD Software & Services (TSXV: DOC) reported its second-quarter financials. CloudMD’s revenue was...

Thursday, September 3, 2020, 02:37:00 PM

CloudMD Closes On $60 Million Acquisition Of VisionPros

CloudMD Software & Services (TSXV: DOC) this morning announced the closing of the acquisition of...

Thursday, June 24, 2021, 08:14:28 AM

CloudMD Posts $40.3 Million In Revenue, $44.2 Million Net Loss In Q2 2022

CloudMD Software & Services Inc. (TSXV: DOC) reported on Monday its Q2 2022 financials, highlighting...

Tuesday, August 23, 2022, 10:22:01 AM

CloudMD: Canaccord Raises Price Target To $3.75

Wednesday morning, it was announced that CloudMD Software & Services (TSXV: DOC) is acquiring VisionPros,...

Friday, February 19, 2021, 04:01:00 PM